A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

AIMS: Androgen deprivation therapy (ADT), usually achieved with luteinising hormone releasing hormone analogues (LHRHa), is central to prostate cancer management. LHRHa reduce both testosterone and oestrogen and are associated with significant long-term toxicity. Previous use of oral oestrogens as A...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Oncol (R Coll Radiol)
Main Authors: Gilbert, D.C., Nankivell, M., Rush, H., Clarke, N.W., Mangar, S., Al-hasso, A., Rosen, S., Kockelbergh, R., Sundaram, S.K., Dixit, S., Laniado, M., McPhail, N., Shaheen, A., Brown, S., Gale, J., Deighan, J., Marshall, J., Duong, T., Macnair, A., Griffiths, A., Amos, C.L., Sydes, M.R., James, N.D., Parmar, M.K.B., Langley, R.E.
Formato: Artigo
Idioma:Inglês
Publicado: 2024
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7617162/
https://ncbi.nlm.nih.gov/pubmed/37973477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clon.2023.10.054
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares